Is the consolidation over?Amazon can break out the cloud and continue to the upside I have placed a buy order at 3280 when we reach that price probably the conversion line will cross above the base line and continue to the upside red line will be my stop loss level, currently it is ranging within the symmetrical triangle I have placed the buy order in case it breaks out
Ichimoku_trader
ichimoku cloud- Part 1 just talking about iichimoku base
skip from how this japanese indicator will calculate and focusing on how we can use this powerful indicator
sorry
1- let to consider base line
(BL) and convention line(CL) are EMA, BL is fast and CL is slow. so all the rules of EMA's are applicable for these lines also.
2- lagging line (LL) is a line chart just 26 candle back. i mean if you see the chart in line chart mode it will plot a line for you, now shift it for 26 candle back so you have LL. lagging
3- the color of the cloud is not important just take long above the cloude and take below the cloud.
4- just whach when the price is inside the cloud.
the first simple strategy is here, now let to backtest.....
AUDJPY ICHIMOKU SAYS OF SELLINGGreeting Traders.
We have shown two lines here, one is red and blue which is red one is Kijun Sen and one is a blue line is called Tekken Sen.
when the blue line crosses the downside of the red line, the movement of the market will be down
Right now I think the movement of the market will be down.
Thank you.
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
AUDNZD - key momentWe are in a downward trend.
KUMO is facing down, SSA is facing down.
SSB flat and will be for some time, as long as the new MINIMUM in the period 52 is not broken.
Flat SSB can substantially impact the PRICE (attracting it to itself), which can further strengthen SUPPORT AREA A (the area between 1.05349 and 1.045283).
CHIKOU SPAN is also approaching SUPPORT AREA A and in the Week 1 chart of the SSB line, which additionally strengthening the support zone.
The critical moment will be the breakthrough of SUPPORT ZONE A; the PRICE after a possible retest of the zone will move towards TP1 (ranges N and V levels 1.04552 and 1.04336 respectively).
The next TP2 is set to range E, which coincides with the next level of support.
The rebound (possibly even several times) of the PRICE from SUPPORT AREA A negates the above scenario. It will cause the PRICE to consolidate, which may change the direction of movement (trend).
CHFJPY - in CONSOLIDATION ( ICHIMOKU)STRONG CONSOLIDATION
The flat KIJUN SEN, TENKAN SEN, SENKOU SPAN B (SSB) indicate that we are in consolidation in all periods (short, medium, and long).
CLOUD flat confirms consolidation.
PRICE fluctuates (oscillate) around the marked BALANCE AREA but currently has a downward trend tendency.
Breaking the 116.269 or 113.593 will signal that a trend (up or down) appears.
CHFJPY
COVID19 AND THE VIX -- daily Ichimoku cloud breaksin the recent past, when we see a Ichimoku Cloud break in the VIX ( Volatility S&P 500 Index ) we see a strong acceleration upwards. The most recent example of this was on 13 Feb 2020
Inversely proportional to the VIX , the S&P 500 Index had a significant breakdown, represented on 21 Feb 2020
Since COVID19 outbreak, governments around the world have been scrambling to control their domestic economies by stimulus and monetisation of debt stoking Global Hyperinflation, and now real people are starting to feel the economic effects of Lockdowns and COVID19 travel and border restrictions.
Currently TVC:SPX is entering the cloud, and the VIX is coiling to break through the cloud.
This is true for other Major Indices around the world.
Northern Hemisphere is entering their "winter flu season" and USA has their contentious Presidential Election looming in NOV. This could be shaping up for a BIG BOUT of VOLATILITY....
$4672.50 in 2006 to $6.00 - Huge Demand, Robust EarningsPacific Ethanol, Inc. produces and markets low-carbon renewable fuels and alcohol products in the United States. The company operates in two segments, Production and Marketing. It produces and markets ethanol; and co-products, such as wet and dry distillers grains, wet and dry corn gluten feed, condensed distillers solubles, corn gluten meal, corn germ, corn oil, dried yeast, and CO2, as well as markets ethanol produced by third parties. The company also offers ethanol transportation, storage, and delivery services through third-party service providers. It sells ethanol to integrated oil companies and gasoline marketers; distillers grains and other feed co-products to dairies and feedlots; and corn oil to poultry and biodiesel customers. The company owns and operates nine ethanol production facilities, including four plants located in the Western states of California, Oregon, and Idaho; and five plants in the Midwestern states of Illinois and Nebraska. Pacific Ethanol, Inc. was founded in 2003 and is headquartered in Sacramento, California.
I think this is the beginning of something huge. As I noted, the stock hit a high of $4672.50 in 2006.
Demand for Alcohol products in the United States and around the World is outstripping supply as can be seen in Pacific Ethanol's last earnings report below.
The company continues to pay down its debt too.
August 11, 2020
Shares of Pacific Ethanol (NASDAQ:PEIX) moved higher by 38.29% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 258.82% over the past year to $0.27, which beat the estimate of ($0.20). Revenue of $212,074,000 beat the estimate of $174,200,000.
This is a pure turnaround play in my opinion with a lot of room to run a lot higher.
Daily Chart is Bullish with most indicators trending up, Bullish
The stock continues to make new 52-week highs.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
XAUUSD, 4hr tf, sell on triangle breakout with ichimoku updatedHello my friends,
Today is such a good day for me. I posted about selling XAUSD on September 4th from 1937, price took my sell order and today it was closed in profit
This XAUUSD sell position which i took on September 4th closed with +280 pips profit banking +4% profit as i used 2% risk only.
Price go down to 1908 area and then get rejected aggresively.
That 1908 area is where exactly our take profit placed.
Congratultions to everyone following this sell call from me.
Follow me and give me thumbs up if you enjoy my call.
Also stay tuned for my next post.
GBPCHF, daily tf, bulls in control after 3 weeks consolidationHello my friends,
Here is a good setup for GBPCHF pairs, price has failed to closed above 1.2030 resitance since August 3rd. The first time GBPCHF reach it, they got rejected and price then consolidating for 3 weeks. Finally the Friday candle closed above it and i think GBPCHF ready to go higher from this point
There is a chance during Monday, price could go down to retest 1.2030 as a support, this will be our cue to buy GBPCHF on the retest.
I am gonna buy GBPCHF if it come to retest it on Monday.
The nearest resistance is at 1.2200 area, after price breaking above this area it could be a highway until 1.24500
Buy GBPCHF 1.2030
Stop loss 1.1890
Take profit 1 @1.2200
Take profit 2 @1.2450
RR ratio 1:3
Good luck
USDJPY, daily tf, potential shoulders head pattern below kumo(2)Hello everyone,
I am updating my recent USDJPY position taken at 106.40.
I took my first sell position at 25th August 2020 and price just start going my way at Friday. It first went against my position but luckily it never hit my SL so i am still safe.
I've taken partial profit as price hit 105.40 which is +100 pips profit.
Stop loss already moved to entry and now i will hold this pair for next TP at 104.00
I am actually quite interested to add more sell position but tomorrow will be monthly candle closing so i will hold it until September.
Good luck to those who sell USDJPY with me
GBPCAD Possible LongPossible Golden TK Cross on daily timeframe may send this pair flying. My entry point was a bit risky due to the bearish cross on the daily but this pair found some good support off the weekly level (touched TK on the weekly and bounced right up). Given that, I found a good entry point on the 4hr timeframe that allowed me to have great RR ratio. The momentum of the bounce has this price almost ready for a golden cross.
If we follow the momentum on this pair, the golden cross on the daily timeframe may yield a bullish golden cross on the weekly level pushing this pair to higher levels. If this occurs, the weekly levels of .8400 could be possible. This would coincide with the monthly bullish cross, retest of both Kijun Sen and Tenkan Sen to the upside.
Entry: .73586
Stop: .7300
TP1: .76450
TP2: Open
Bullish Charts - Online Learning in ChinaRYB Education, Inc. provides early childhood education service in the People's Republic of China. The company offers kindergarten services to 2-6-year-old children; and play-and-learn centers services for the joint participation of 0-6-year-old children and their adult family members to promote children's development, foster bonding with family, and prepare them for their entry into kindergartens and primary schools. It also develops and sells educational products and services, such as teaching aids, educational toys, at-home educational products, and school uniforms through franchisees and other business partners, as well as directly to a market of families. As of December 31, 2019, it operated 100 directly operated and 250 franchise kindergartens; and 6 play-and-learn centers. The company was formerly known as Top Margin Limited and changed its name to RYB Education, Inc. in June 2017. RYB Education, Inc. was founded in 1998 and is based in Beijing, China.
Daily Chart is Bullish
Broke out above the cloud yesterday.
Indicators are Bullish
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Disposable Surgical Robotic Device - BIG News Coming 8/17/20Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System
Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference
HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System.
finance.yahoo.com
On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00.
I think this device could be a game changer.
Disposable medical devices is where the future is going especially for sanitary reasons.
Watch this stock Monday, 8/17/2020, it could run hard.
I think the stock has been consolidating for a while and is coiling and ready to explode higher.
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Beat Earnings. Raised Guidance. No Debt. USA Protective GearAlpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel and infection control, and building supply products in the United States and internationally. The company operates through two segments, Building Supply and Disposable Protective Apparel. The Building Supply segment offers construction weatherization products, such as house wrap, synthetic roof underlayment, and other woven materials. The Disposable Protective Apparel segment provides shoecovers, bouffant caps, gowns, coveralls, lab coats, hoods, and frocks, as well as face masks and face shields. The company provides its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; pharmaceutical markets; and building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
Net Sales of $25.5 Million, an Increase of 123.4% Year-over-Year
Provides Update on Orders for Personal Protective Equipment (PPE)
Net sales for the second quarter of 2020 were $25.5 million, compared to $11.4 million for the second quarter of 2019, up 123.4% year-over-year.
Net income for the second quarter of 2020 was $6.2 million, or $0.46 per diluted share, compared to $1.0 million, or $0.08 per diluted share, for the second quarter of 2019, up 475% on a per share basis.
NOGALES, Ariz., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three month period ended June 30, 2020.
finance.yahoo.com
Need I say anymore? Earnings blew past Wall Street Estimates. APT raised guidance and the company has no debt.
Protective gear and N95 masks will be a part of the Worldwide dress code through 2020 and into 2021 even if a vaccine is approved because not everyone will want to take the vaccine shot.
Today's sell off was outrageous and an early Christmas gift for anyone looking for a quality company that makes protective gear & N95 masks in the USA!
Target: $32
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Huge Earrings BeatDURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for pharmaceutical and medical device clients for use as raw materials in their products under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase I and II development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's oral and injectable delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Zogenix, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.
This morning Durect reported earrings that blew away Wall Street Estimates.
Q2 EPS $0.07 Up From $(0.04) YoY, Sales $25 Million Beat $11.48 Million Estimate
Sales more than doubled estimates.
Daily Chart is Bullish
Indicators are rising, Bullish
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Rapid Recovery Respiratory Failure - COVID-19 TreatmentRelief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary hypertension; and atexakin alfa that has completed Phase I clinical trial to treat peripheral diabetic neuropathy. Relief Therapeutics Holding AG is based in Geneva, Switzerland.
RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells
- Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) was seen in patients with severe medical comorbidities after three days of treatment with RLF-100 under FDA Emergency Use IND authorization at multiple clinical sites
- Aviptadil is being developed as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes
- RLF-100 is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide VIP), which has been granted FDA Fast Track Designation, FDA emergency use IND authorization, and an expanded access protocol
finance.yahoo.com
I think this stock could spike like Moderna
Long!
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Bullish Charts - Plasma Play, FDA Approved Plasma FacilitiesADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
BREAKING NEWS TODAY - 07/30/2020
ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients.
www.benzinga.com
On July 6, 20, ADMA opened a new plasma facility and is awaiting emergency authorization for a second location.
finance.yahoo.com
With the FDA asking for everyone to donate plasma, this stock could rip!
Plasma stocks ripped today and continue to rip.
This company already is up and running one plasma facility.
Game On!
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.